URMC plays key role in new Huntington’s drug
STAFF REPORTS news@allwnynews.com ROCHESTER — University of Rochester Medical Center (URMC) researchers were instrumental in the U.S. Food and Drug Administration’s (FDA) recent approval of SD-809 (deutetrabenazine) to treat Huntington’s…